Eton stock catapulted to a record high Friday after the biotech company smashed second-quarter sales forecasts and hiked its guidance for the year. The company sells treatments for rare diseases and pediatric endocrinology. During the June quarter, Eton Pharmaceuticals (ETON) generated $37.6 million in sales. Sales skyrocketed 99% and handily beat expectations for $27.1 million, according to FactSet.
Bankomat
Eton Pharmaceuticals Stock Soars to Record High
News|2026/08/14 14:36
Eton Pharmaceuticals Exceeds Second Quarter Sales Forecasts
Share
Read also
NewsVil Food’s canned fruit and vegetable production suspended
October 16, 202622:01
NewsRussia and the US discuss cooperation in data centers
October 16, 202620:01
NewsWaymo to launch robotaxi service in Toronto in 2028
October 16, 202618:28
NewsArmenia ranks last in geological exploration spending per square kilometre
October 16, 202618:03